scholarly journals The Bevacizumab “Pseudoresponse” in Glioma: Disappointment or Opportunity?

Author(s):  
Piia Thomas ◽  
Daniel Spielman ◽  
Lawrence Recht
Sign in / Sign up

Export Citation Format

Share Document